Daily low-dose hCG stimulation during the luteal phase combined with GnRHa triggered IVF cycles without exogenous progesterone: A proof of concept trial

Human Reproduction

Volumn 30, Issue 10, 2015, Pages 2387-2395

  Andersen, Claus Yding ^a,b   Elbaek, Helle Olesen ^c   Alsbjerg, Birgit ^c,d   Laursen, Rita Jakubcionyte ^c   Povlsen, Betina Boel ^c   Thomsen, Lise ^c,d   Humaidan, Peter ^c,d  

^a Rigshospitalet   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c SKIVE REGIONAL HOSPITAL   (Denmark)

^d AARHUS UNIVERSITY   (Denmark)

Author keywords

GnRH antagonist; GnRHa trigger; HCG for follicular stimulation; IVF; IVF stimulation; Low dose hCG; Luteal phase support

Indexed keywords

CETRORELIX; PROGESTERONE; RECOMBINANT FOLLITROPIN; CHORIONIC GONADOTROPIN; FERTILITY PROMOTING AGENT; FOLLITROPIN; GONADORELIN; LHRH, ALA(6)-GLY(10)-ETHYLAMIDE-;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; FEMALE; FERTILIZATION IN VITRO; HUMAN; LOW DRUG DOSE; LUTEAL PHASE; MAJOR CLINICAL STUDY; OOCYTE; OOCYTE RETRIEVAL; OVARY FOLLICLE MATURATION; OVARY HYPERSTIMULATION; OVULATION INDUCTION; RANDOMIZED CONTROLLED TRIAL; REPRODUCTION; STANDARD; ANALOGS AND DERIVATIVES; ANTAGONISTS AND INHIBITORS; BLOOD; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; FOLLICULAR PHASE; INFERTILITY; METABOLISM; OVARIAN HYPERSTIMULATION SYNDROME; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY RATE; PROCEDURES; TIME FACTOR; TREATMENT OUTCOME;

ADULT; CHORIONIC GONADOTROPIN; FEMALE; FERTILITY AGENTS, FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; FOLLICULAR PHASE; GONADOTROPIN-RELEASING HORMONE; HUMANS; INFERTILITY; LUTEAL PHASE; OOCYTES; OVARIAN HYPERSTIMULATION SYNDROME; OVULATION INDUCTION; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY RATE; PROGESTERONE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84943303203     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/dev184     Document Type: Article

References (26)

1. Abecia JA, Lozano JM, Forcada F, Zarazaga L. Effect of level of dietary energy and protein on embryo survival and progesterone production on day eight of pregnancy in Rasa Aragonesa ewes. Anim Reprod Sci 1997;48:209-218.
2. Beckers NG, Macklon NS, Eijkemans MJ, Ludwig M, Felberbaum RE, Diedrich K, Bustion S, Loumaye E, Fauser BC. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropinreleasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment. J Clin Endocrinol Metab 2003;88:4186-4192.
3. Blockeel C, De VM, VerpoestW, Stoop D, Haentjens P, Devroey P. Can 200 IU of hCG replace recombinant FSH in the late follicular phase in a GnRH-antagonist cycle? A pilot study. Hum Reprod 2009;24:2910-2916.
4. Damewood MD, Shen W, Zacur HA, Schlaff WD, Rock JA, Wallach EE. Disappearance of exogenously administered human chorionic gonadotropin. Fertil Steril 1989;52:398-400.
5. Devoto L, Fuentes A, Kohen P, Cespedes P, Palomino A, Pommer R, Munoz A, Strauss JF III. The human corpus luteum: life cycle and function in natural cycles. Fertil Steril 2009;92:1067-1079.
6. Edwards RG, Steptoe PC, Purdy JM. Establishing full-term human pregnancies using cleaving embryos grown in vitro. Br J Obstet Gynaecol 1980;87: 737-756.
7. Fauser BC, Devroey P. Reproductive biology and IVF: ovarian stimulation and luteal phase consequences. Trends Endocrinol Metab 2003;14:236-242.
8. Fauser BC, de Jong D, Olivennes F, Wramsby H, Tay C, Itskovitz-Eldor J, van Hooren HG. Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after cotreatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for in vitro fertilization. J Clin Endocrinol Metab 2002;87:709-715.
9. Filicori M, Cognigni GE, Tabarelli C, Pocognoli P, Taraborrelli S, Spettoli D, Ciampaglia W. Stimulation and growth of antral ovarian follicles by selective LH activity administration in women. J Clin Endocrinol Metab 2002;87:1156-1161.
10. Filicori M, Cognigni GE, Gamberini E, Parmegiani L, Troilo E, Roset B. Efficacy of low-dose human chorionic gonadotropin alone to complete controlled ovarian stimulation. Fertil Steril 2005;84:394-401.
11. Gonen Y, Balakier H, PowellW, Casper RF. Use of gonadotropin-releasing hormone agonist to trigger follicular maturation for in vitro fertilization. J Clin Endocrinol Metab 1990;71:918-922.
12. Hoff JD, Quigley ME, Yen SS. Hormonal dynamics at midcycle: a reevaluation. J Clin Endocrinol Metab 1983;57:792-796.
13. Humaidan P. Luteal phase rescue in high-risk OHSS patients by GnRHa triggering in combination with low-dose HCG: a pilot study. Reprod Biomed Online 2009;18:630-634.
14. Humaidan P, Alsbjerg B. GnRHa trigger for final oocyte maturation: is HCG trigger history? Reprod Biomed Online 2014;29:274-280.
15. Humaidan P, Bredkjaer HE, Bungum L, Bungum M, Grondahl ML, Westergaard L, Andersen CY. GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study. Hum Reprod 2005;20:1213-1220.
16. Humaidan P, Bungum L, Bungum M, Yding Andersen C. Rescue of corpus luteum function with peri-ovulatory HCG supplementation in IVF/ICSI GnRH antagonist cycles in which ovulation was triggered with a GnRH agonist: a pilot study. Reprod Biomed Online 2006;13:173-178.
17. Humaidan P, Ejdrup BH, Westergaard LG, Yding Andersen C. 1, 500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled study. Fertil Steril 2010;93:847-854.
18. Humaidan P, Papanikolaou EG, Kyrou D, Alsbjerg B, PolyzosNP, Devroey P, Fatemi HM. The luteal phase after GnRH-agonist triggering of ovulation: present and future perspectives. Reprod Biomed Online 2012;24: 134-141.
19. Humaidan P, Polyzos NP, Alsbjerg B, Erb K, Mikkelsen AL, Elbaek HO, Papanikolaou EG, Andersen CY. GnRHa trigger and individualized luteal phase hCG support according to ovarian response to stimulation: two prospective randomized controlled multi-centre studies in IVF patients. Hum Reprod 2013;28:2511-2521.
20. Itskovitz J, Boldes R, Levron J, Erlik Y, Kahana L, Brandes JM. Induction of preovulatory luteinizing hormone surge and prevention of ovarian hyperstimulation syndrome by gonadotropin-releasing hormone agonist. Fertil Steril 1991;56:213-220.
21. Jeppesen JV, Kristensen SG, Nielsen ME, Humaidan P, Dal Canto M, Fadini R, Schmidt KT, Ernst E, Yding Andersen C. LH-receptor gene expression in human granulosa and cumulus cells from antral and preovulatory follicles. J Clin Endocrinol Metab 2012;97:E1524-E1531.
22. Kol S, Humaidan P, Itskovitz-Eldor J. GnRH agonist ovulation trigger and hCG-based, progesterone-free luteal support: a proof of concept study. Hum Reprod 2011;26:2874-2877.
23. Smitz J, Devroey P, Faguer B, Bourgain C, Camus M, Van Steirteghem AC. A randomized prospective study comparing supplementation of the luteal phase and early pregnancy by natural progesterone administered by intramuscular or vaginal route. Rev Fr Gynecol Obstet 1992;87:507-516.
24. Tavaniotou A, Devroey P. Effect of human chorionic gonadotropin on luteal luteinizing hormone concentrations in natural cycles. Fertil Steril 2003; 80:654-655.
25. Tavaniotou A, Albano C, Smitz J, Devroey P. Comparison of LH concentrations in the early and mid-luteal phase in IVF cycles after treatment with HMG alone or in association with the GnRH antagonist Cetrorelix. Hum Reprod 2001;16:663-667.
26. Yding Andersen C, Vilbour Andersen K. Improving the luteal phase after ovarian stimulation: reviewing new options. Reprod Biomed Online 2014; 28:552-559.